Bandingkan Harga & Kinerja Akbar Indo Makmur Stimec Tbk (AIMS) vs UBC Medical Indonesia Tbk. (LABS)

Akbar Indo Makmur Stimec TbkTrading

UBC Medical Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Akbar Indo Makmur Stimec Tbk dan UBC Medical Indonesia Tbk.: Akbar Indo Makmur Stimec Tbk diperdagangkan di Rp390 (kapitalisasi pasar 86,24 M, volume 24 jam 183 rb), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp162 (kapitalisasi pasar 635,95 M, volume 24 jam 230,6 rb). Perbedaan utamanya: UBC Medical Indonesia Tbk. jauh lebih besar — sekitar 7,4× kapitalisasi pasar Akbar Indo Makmur Stimec Tbk, dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (230,6 rb vs 183 rb). Mana yang lebih baik tergantung tujuan investasimu.

	AIMS	LABS
Kapitalisasi Pasar	86,24 M	635,95 M
Volume	183 rb	230,6 rb
Lot	1,83 rb	2,31 rb
Perputaran	71,64 jt	37,51 jt
Harga Rata-rata	391,49	162,65
Nilai Transaksi	71,64 jt	37,51 jt
Harga Ekuilibrium Indikatif	—	163
Volume Ekuilibrium Indikatif	—	16

Lihat detail →Lihat detail →

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

AIMS

Lihat detail →

LABS

Lihat detail →

Tentang Akbar Indo Makmur Stimec Tbk

PT. Akbar Indo Makmur Tbk was established on May 7th 1997. On November 17th, 2000, PT. Stimec merged by PT. Akbar Indo Makmur and changed to be PT. Akbar Indo Makmur Stimec.

Selengkapnya di halaman AIMS →

Tentang UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Selengkapnya di halaman LABS →